372 related articles for article (PubMed ID: 24818887)
1. Enhanced antitumor efficacy of folate modified amphiphilic nanoparticles through co-delivery of chemotherapeutic drugs and genes.
Yu B; Tang C; Yin C
Biomaterials; 2014 Aug; 35(24):6369-78. PubMed ID: 24818887
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable nanoparticles based on linoleic acid and poly(beta-malic acid) double grafted chitosan derivatives as carriers of anticancer drugs.
Zhao Z; He M; Yin L; Bao J; Shi L; Wang B; Tang C; Yin C
Biomacromolecules; 2009 Mar; 10(3):565-72. PubMed ID: 19175304
[TBL] [Abstract][Full Text] [Related]
3. Effects of poly(ethylene glycol) grafting density on the tumor targeting efficacy of nanoparticles with ligand modification.
Zhang S; Tang C; Yin C
Drug Deliv; 2015 Feb; 22(2):182-90. PubMed ID: 24215373
[TBL] [Abstract][Full Text] [Related]
4. Enhanced antitumor efficacy of arginine modified amphiphilic nanoparticles co-delivering doxorubicin and iSur-pDNA via the multiple synergistic effect.
Song Y; Tang C; Yin C
Biomaterials; 2018 Jan; 150():1-13. PubMed ID: 29028548
[TBL] [Abstract][Full Text] [Related]
5. Effects of hydrophobic and hydrophilic modifications on gene delivery of amphiphilic chitosan based nanocarriers.
Wang B; He C; Tang C; Yin C
Biomaterials; 2011 Jul; 32(20):4630-8. PubMed ID: 21440295
[TBL] [Abstract][Full Text] [Related]
6. Oral delivery of shRNA based on amino acid modified chitosan for improved antitumor efficacy.
Zheng H; Tang C; Yin C
Biomaterials; 2015 Nov; 70():126-37. PubMed ID: 26310108
[TBL] [Abstract][Full Text] [Related]
7. Enhanced antitumor efficacy of glutathione-responsive chitosan based nanoparticles through co-delivery of chemotherapeutics, genes, and immune agents.
Zhang L; Li Q; Chen J; Tang C; Yin C
Carbohydr Polym; 2021 Oct; 270():118384. PubMed ID: 34364626
[TBL] [Abstract][Full Text] [Related]
8. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
[TBL] [Abstract][Full Text] [Related]
9. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
10. Oral delivery of shRNA and siRNA via multifunctional polymeric nanoparticles for synergistic cancer therapy.
Han L; Tang C; Yin C
Biomaterials; 2014 May; 35(15):4589-600. PubMed ID: 24613049
[TBL] [Abstract][Full Text] [Related]
11. Self-aggregated nanoparticles of linoleic acid-modified glycol chitosan conjugate as delivery vehicles for paclitaxel: preparation, characterization and evaluation.
Yu J; Liu Y; Zhang L; Zhao J; Ren J; Zhang L; Jin Y
J Biomater Sci Polym Ed; 2015; 26(18):1475-89. PubMed ID: 26489688
[TBL] [Abstract][Full Text] [Related]
12. Co-Delivery of Doxorubicin and Survivin shRNA-Expressing Plasmid Via Microenvironment-Responsive Dendritic Mesoporous Silica Nanoparticles for Synergistic Cancer Therapy.
Li Z; Zhang L; Tang C; Yin C
Pharm Res; 2017 Dec; 34(12):2829-2841. PubMed ID: 28948461
[TBL] [Abstract][Full Text] [Related]
13. Targeted antitumor comparison study between dopamine self-polymerization and traditional synthesis for nanoparticle surface modification in drug delivery.
Zhang M; Zou Y; Zuo C; Ao H; Guo Y; Wang X; Han M
Nanotechnology; 2021 May; 32(30):. PubMed ID: 33862617
[TBL] [Abstract][Full Text] [Related]
14. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
15. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles.
Han S; Liu Y; Nie X; Xu Q; Jiao F; Li W; Zhao Y; Wu Y; Chen C
Small; 2012 May; 8(10):1596-606. PubMed ID: 22411637
[TBL] [Abstract][Full Text] [Related]
16. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes.
Jin M; Jin G; Kang L; Chen L; Gao Z; Huang W
Int J Nanomedicine; 2018; 13():2405-2426. PubMed ID: 29719390
[TBL] [Abstract][Full Text] [Related]
17. Hexanoic acid and polyethylene glycol double grafted amphiphilic chitosan for enhanced gene delivery: influence of hydrophobic and hydrophilic substitution degree.
Layek B; Haldar MK; Sharma G; Lipp L; Mallik S; Singh J
Mol Pharm; 2014 Mar; 11(3):982-94. PubMed ID: 24499512
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of doxorubicin and interleukin-2 via chitosan based nanoparticles for enhanced antitumor efficacy.
Wu J; Tang C; Yin C
Acta Biomater; 2017 Jan; 47():81-90. PubMed ID: 27729232
[TBL] [Abstract][Full Text] [Related]
19. Trimethyl chitosan based conjugates for oral and intravenous delivery of paclitaxel.
He R; Yin C
Acta Biomater; 2017 Apr; 53():355-366. PubMed ID: 28189812
[TBL] [Abstract][Full Text] [Related]
20. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.
Su C; Li H; Shi Y; Wang G; Liu L; Zhao L; Su R
Int J Pharm; 2014 Oct; 474(1-2):202-11. PubMed ID: 25149123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
